Advertisement

Topics

Melanocyte Stimulating Hormone Receptor Melanocortin Receptor 1 or MSHR or MC1R Pipeline Review, H1 2018 [Report Updated: 13032018] Prices from USD $3500

13:01 EDT 14 Mar 2018 | BioPortfolio Report Blog

Melanocyte Stimulating Hormone Receptor Melanocortin Receptor 1 or MSHR or MC1R Pipeline Review, H1 2018


Summary


Melanocyte Stimulating Hormone Receptor Melanocortin Receptor 1 or MSHR or MC1R Melanocytestimulating hormone receptor MSHR also known as melanocortin 1 receptor MC1R, is a G proteincoupled receptor that binds to a peptide hormones known as the melanocortins, which include adrenocorticotropic hormone ACTH.


When activated by alphaMSH, MC1R initiates a complex signaling cascade that leads to the production of the brown or black pigment eumelanin. The receptor also antagonize by agouti signaling peptide which reverts the cell back to producing the yellow or red phaeomelanin.


Melanocyte Stimulating Hormone Receptor Melanocortin Receptor 1 or MSHR or MC1R pipeline Target constitutes close to 9 molecules. Out of which approximately 9 molecules are developed by Companies. The molecules developed by companies in PreRegistration, Phase II, Phase I and Preclinical stages are 1, 1, 2 and 5 respectively.


Report covers products from therapy areas Dermatology, Gastrointestinal, Musculoskeletal Disorders, Ophthalmology, Central Nervous System, Genetic Disorders, Genito Urinary System And Sex Hormones and Oncology which include indications Inflammatory Bowel Disease, Vitiligo, Amyotrophic Lateral Sclerosis, Gouty Arthritis Gout, Kidney Disease, Metastatic Melanoma, Ocular Inflammation, Peritonitis, Porphyria Erythropoietic Protoporphyri, Psoriatic Arthritis, Ulcerative Colitis and Uveitis.


The latest report Melanocyte Stimulating Hormone Receptor Pipeline Review, H1 2018, outlays comprehensive information on the Melanocyte Stimulating Hormone Receptor Melanocortin Receptor 1 or MSHR or MC1R targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action MoA, route of administration RoA and molecule type.


It also reviews key players involved in Melanocyte Stimulating Hormone Receptor Melanocortin Receptor 1 or MSHR or MC1R targeted therapeutics development with respective active and dormant or discontinued projects.


The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industryspecific third party sources.


Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.


Scope


The report provides a snapshot of the global therapeutic landscape for Melanocyte Stimulating Hormone Receptor Melanocortin Receptor 1 or MSHR or MC1R

The report reviews Melanocyte Stimulating Hormone Receptor Melanocortin Receptor 1 or MSHR or MC1R targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industryspecific sources

The report covers pipeline products based on various stages of development ranging from preregistration till discovery and undisclosed stages

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, RD brief, licensing and collaboration details other developmental activities

The report reviews key players involved in Melanocyte Stimulating Hormone Receptor Melanocortin Receptor 1 or MSHR or MC1R targeted therapeutics and enlists all their major and minor projects

The report assesses Melanocyte Stimulating Hormone Receptor Melanocortin Receptor 1 or MSHR or MC1R targeted therapeutics based on mechanism of action MoA, route of administration RoA and molecule type

The report summarizes all the dormant and discontinued pipeline projects

The report reviews latest news and deals related to Melanocyte Stimulating Hormone Receptor Melanocortin Receptor 1 or MSHR or MC1R targeted therapeutics


Reasons to buy


Gain strategically significant competitor information, analysis, and insights to formulate effective RD strategies

Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage

Identify and understand the targeted therapy areas and indications for Melanocyte Stimulating Hormone Receptor Melanocortin Receptor 1 or MSHR or MC1R

Identify the use of drugs for target identification and drug repurposing

Identify potential new clients or partners in the target demographic

Develop strategic initiatives by understanding the focus areas of leading companies

Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Melanocyte Stimulating Hormone Receptor Melanocortin Receptor 1 or MSHR or MC1R development landscape

Develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Original Article: Melanocyte Stimulating Hormone Receptor Melanocortin Receptor 1 or MSHR or MC1R Pipeline Review, H1 2018 [Report Updated: 13032018] Prices from USD $3500

NEXT ARTICLE

More From BioPortfolio on "Melanocyte Stimulating Hormone Receptor Melanocortin Receptor 1 or MSHR or MC1R Pipeline Review, H1 2018 [Report Updated: 13032018] Prices from USD $3500"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Endocrine Disorders
Endocrine disorders are grouped into two categories: hormone imbalance - when a gland produces too much or too little of an endocrine hormone development of lesions (such as nodules or tumors) in the endocrine system, which may or may not affect...

Endocrinology
Diabetes Diabetes Endocrine Obesity Oxycontin Renal Disease Thyroid Disorders Endocrinology is the study of the endocrine glands and the hormones that they secrete (Oxford Medical Dictionary). There are several groups of h...